25 XP   0   0   10

BioLight Life Sciences Ltd
Buy, Hold or Sell?

Let's analyse BioLight Life Sciences Ltd together

PenkeI guess you are interested in BioLight Life Sciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioLight Life Sciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BioLight Life Sciences Ltd

I send you an email if I find something interesting about BioLight Life Sciences Ltd.

Quick analysis of BioLight Life Sciences Ltd (30 sec.)










What can you expect buying and holding a share of BioLight Life Sciences Ltd? (30 sec.)

How much money do you get?

How much money do you get?
ILA0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
ILA1,173.28
Expected worth in 1 year
ILA498.05
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
ILA-675.23
Return On Investment
-161.8%

For what price can you sell your share?

Current Price per Share
ILA417.40
Expected price per share
ILA0 - ILA558.30
How sure are you?
50%

1. Valuation of BioLight Life Sciences Ltd (5 min.)




Live pricePrice per Share (EOD)

ILA417.40

Intrinsic Value Per Share

ILA-756.02 - ILA996.51

Total Value Per Share

ILA417.26 - ILA2,169.79

2. Growth of BioLight Life Sciences Ltd (5 min.)




Is BioLight Life Sciences Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$14.6m$16.7m-$2.1m-14.4%

How much money is BioLight Life Sciences Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m$103.9k-$2.2m-104.9%
Net Profit Margin-12,455.6%12,733.3%--

How much money comes from the company's main activities?

3. Financial Health of BioLight Life Sciences Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of BioLight Life Sciences Ltd? (5 min.)

Welcome investor! BioLight Life Sciences Ltd's management wants to use your money to grow the business. In return you get a share of BioLight Life Sciences Ltd.

What can you expect buying and holding a share of BioLight Life Sciences Ltd?

First you should know what it really means to hold a share of BioLight Life Sciences Ltd. And how you can make/lose money.

Speculation

The Price per Share of BioLight Life Sciences Ltd is ILA417.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BioLight Life Sciences Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BioLight Life Sciences Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ILA1,173.28. Based on the TTM, the Book Value Change Per Share is ILA-168.81 per quarter. Based on the YOY, the Book Value Change Per Share is ILA28.63 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ILA0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BioLight Life Sciences Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per Share
Usd Eps-0.47-0.1%-0.47-0.1%0.020.0%0.380.1%-0.41-0.1%
Usd Book Value Change Per Share-0.46-0.1%-0.46-0.1%0.080.0%0.540.1%0.100.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.46-0.1%-0.46-0.1%0.080.0%0.540.1%0.100.0%
Usd Price Per Share1.85-1.85-3.14-2.57-5.34-
Price to Earnings Ratio-3.97--3.97-138.25-25.87-9.50-
Price-to-Total Gains Ratio-4.03--4.03-40.31-5.71-5.34-
Price to Book Ratio0.58-0.58-0.86-0.67-3.60-
Price-to-Total Gains Ratio-4.03--4.03-40.31-5.71-5.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.135328
Number of shares880
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.460.54
Usd Total Gains Per Share-0.460.54
Gains per Quarter (880 shares)-404.06477.66
Gains per Year (880 shares)-1,616.221,910.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1616-1626019111901
20-3232-3242038213812
30-4849-4858057325723
40-6465-6474076437634
50-8081-8090095539545
60-9697-970601146411456
70-11314-1132201337413367
80-12930-1293801528515278
90-14546-1455401719617189
100-16162-1617001910619100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.08.00.020.0%3.08.05.018.8%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%8.08.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.016.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%8.08.00.050.0%

Fundamentals of BioLight Life Sciences Ltd

About BioLight Life Sciences Ltd

BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions. The company's ophthalmic product offering and pipeline of product candidates include DiagnosTear's TeaRx technology, a diagnostic platform for diagnosis of disease in the frontal areas of the eye through examination of a number of substances in the composition of teardrops; ViSci, an Eye D technology that treats glaucoma by the insertion of a sub conjunctival implant; OphRx that develops drugs for treating eye diseases; and Peripherex, which develops solutions for at-home and in-office diagnosis and monitoring of peripheral vision impairment used by eye care and other providers to diagnose and monitor glaucoma and other diseases. Its pipeline also include AEYE that develops artificial intelligence solutions for a variety of retinal diseases; Tarsier, which develops TRS 01 based on its technological platform for the treatment of Uveitis in patients suffering from high IPO; Belkin Vision that develops clinic fast and automatic laser device to enable glaucoma patients to receive short & effective treatments as treatment to lower IOP; and Sanoculis, which develops an innovative surgical procedure for the treatment of the Glaucoma. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was incorporated in 2005 and is based in Tel Aviv, Israel.

Fundamental data was last updated by Penke on 2024-03-20 12:05:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of BioLight Life Sciences Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit BioLight Life Sciences Ltd earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare BioLight Life Sciences Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -12,455.6% means that -124.56 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioLight Life Sciences Ltd:

  • The MRQ is -12,455.6%. The company is making a huge loss. -2
  • The TTM is -12,455.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-12,455.6%TTM-12,455.6%0.0%
TTM-12,455.6%YOY12,733.3%-25,188.9%
TTM-12,455.6%5Y-9,071.2%-3,384.4%
5Y-9,071.2%10Y-7,462.9%-1,608.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12,455.6%-159.2%-12,296.4%
TTM-12,455.6%-202.3%-12,253.3%
YOY12,733.3%-263.0%+12,996.3%
5Y-9,071.2%-452.4%-8,618.8%
10Y-7,462.9%-589.0%-6,873.9%
1.1.2. Return on Assets

Shows how efficient BioLight Life Sciences Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BioLight Life Sciences Ltd to the Biotechnology industry mean.
  • -13.8% Return on Assets means that BioLight Life Sciences Ltd generated -0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioLight Life Sciences Ltd:

  • The MRQ is -13.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM-13.8%0.0%
TTM-13.8%YOY0.6%-14.4%
TTM-13.8%5Y4.4%-18.1%
5Y4.4%10Y-25.2%+29.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.8%-12.5%-1.3%
TTM-13.8%-12.2%-1.6%
YOY0.6%-11.2%+11.8%
5Y4.4%-13.3%+17.7%
10Y-25.2%-14.6%-10.6%
1.1.3. Return on Equity

Shows how efficient BioLight Life Sciences Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BioLight Life Sciences Ltd to the Biotechnology industry mean.
  • -14.8% Return on Equity means BioLight Life Sciences Ltd generated -0.15 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioLight Life Sciences Ltd:

  • The MRQ is -14.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.8%TTM-14.8%0.0%
TTM-14.8%YOY0.6%-15.4%
TTM-14.8%5Y4.9%-19.6%
5Y4.9%10Y-74.7%+79.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.8%-16.0%+1.2%
TTM-14.8%-15.8%+1.0%
YOY0.6%-13.9%+14.5%
5Y4.9%-18.2%+23.1%
10Y-74.7%-19.1%-55.6%

1.2. Operating Efficiency of BioLight Life Sciences Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient BioLight Life Sciences Ltd is operating .

  • Measures how much profit BioLight Life Sciences Ltd makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BioLight Life Sciences Ltd to the Biotechnology industry mean.
  • An Operating Margin of -16,384.1% means the company generated -163.84  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioLight Life Sciences Ltd:

  • The MRQ is -16,384.1%. The company is operating very inefficient. -2
  • The TTM is -16,384.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-16,384.1%TTM-16,384.1%0.0%
TTM-16,384.1%YOY-353,433.3%+337,049.2%
TTM-16,384.1%5Y-82,121.6%+65,737.5%
5Y-82,121.6%10Y-45,396.3%-36,725.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16,384.1%-299.5%-16,084.6%
TTM-16,384.1%-208.5%-16,175.6%
YOY-353,433.3%-280.2%-353,153.1%
5Y-82,121.6%-459.9%-81,661.7%
10Y-45,396.3%-596.9%-44,799.4%
1.2.2. Operating Ratio

Measures how efficient BioLight Life Sciences Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 164.84 means that the operating costs are 164.84 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of BioLight Life Sciences Ltd:

  • The MRQ is 164.841. The company is inefficient in keeping operating costs low. -1
  • The TTM is 164.841. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ164.841TTM164.8410.000
TTM164.841YOY3,535.333-3,370.492
TTM164.8415Y820.310-655.469
5Y820.31010Y454.409+365.900
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ164.8412.817+162.024
TTM164.8413.181+161.660
YOY3,535.3333.609+3,531.724
5Y820.3105.554+814.756
10Y454.4097.396+447.013

1.3. Liquidity of BioLight Life Sciences Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if BioLight Life Sciences Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.11 means the company has 7.11 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of BioLight Life Sciences Ltd:

  • The MRQ is 7.107. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.107. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.107TTM7.1070.000
TTM7.107YOY15.379-8.272
TTM7.1075Y13.286-6.179
5Y13.28610Y9.079+4.207
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1073.987+3.120
TTM7.1074.440+2.667
YOY15.3795.569+9.810
5Y13.2866.158+7.128
10Y9.0796.492+2.587
1.3.2. Quick Ratio

Measures if BioLight Life Sciences Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BioLight Life Sciences Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 1.20 means the company can pay off 1.20 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioLight Life Sciences Ltd:

  • The MRQ is 1.203. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.203. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.203TTM1.2030.000
TTM1.203YOY0.001+1.201
TTM1.2035Y2.141-0.938
5Y2.14110Y1.278+0.862
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2033.653-2.450
TTM1.2034.158-2.955
YOY0.0015.515-5.514
5Y2.1416.012-3.871
10Y1.2786.206-4.928

1.4. Solvency of BioLight Life Sciences Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of BioLight Life Sciences Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BioLight Life Sciences Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.06 means that BioLight Life Sciences Ltd assets are financed with 5.8% credit (debt) and the remaining percentage (100% - 5.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioLight Life Sciences Ltd:

  • The MRQ is 0.058. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.058. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.058TTM0.0580.000
TTM0.058YOY0.043+0.015
TTM0.0585Y0.081-0.022
5Y0.08110Y0.259-0.178
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0580.336-0.278
TTM0.0580.330-0.272
YOY0.0430.267-0.224
5Y0.0810.367-0.286
10Y0.2590.378-0.119
1.4.2. Debt to Equity Ratio

Measures if BioLight Life Sciences Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BioLight Life Sciences Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 6.2% means that company has 0.06 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioLight Life Sciences Ltd:

  • The MRQ is 0.062. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.062. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.0620.000
TTM0.062YOY0.045+0.017
TTM0.0625Y0.088-0.025
5Y0.08810Y0.688-0.601
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0620.376-0.314
TTM0.0620.398-0.336
YOY0.0450.334-0.289
5Y0.0880.431-0.343
10Y0.6880.476+0.212

2. Market Valuation of BioLight Life Sciences Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings BioLight Life Sciences Ltd generates.

  • Above 15 is considered overpriced but always compare BioLight Life Sciences Ltd to the Biotechnology industry mean.
  • A PE ratio of -3.97 means the investor is paying -3.97 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioLight Life Sciences Ltd:

  • The EOD is -2.434. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.966. Based on the earnings, the company is expensive. -2
  • The TTM is -3.966. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.434MRQ-3.966+1.531
MRQ-3.966TTM-3.9660.000
TTM-3.966YOY138.246-142.211
TTM-3.9665Y25.869-29.835
5Y25.86910Y9.499+16.370
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.434-2.697+0.263
MRQ-3.966-2.422-1.544
TTM-3.966-2.709-1.257
YOY138.246-4.116+142.362
5Y25.869-6.257+32.126
10Y9.499-6.478+15.977
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioLight Life Sciences Ltd:

  • The EOD is -1.982. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.229. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.229. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.982MRQ-3.229+1.247
MRQ-3.229TTM-3.2290.000
TTM-3.229YOY-4.958+1.729
TTM-3.2295Y-3.192-0.036
5Y-3.19210Y-4.207+1.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.982-3.344+1.362
MRQ-3.229-2.939-0.290
TTM-3.229-3.486+0.257
YOY-4.958-5.592+0.634
5Y-3.192-8.464+5.272
10Y-4.207-8.872+4.665
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of BioLight Life Sciences Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.58 means the investor is paying 0.58 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of BioLight Life Sciences Ltd:

  • The EOD is 0.356. Based on the equity, the company is cheap. +2
  • The MRQ is 0.580. Based on the equity, the company is cheap. +2
  • The TTM is 0.580. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.356MRQ0.580-0.224
MRQ0.580TTM0.5800.000
TTM0.580YOY0.860-0.280
TTM0.5805Y0.670-0.091
5Y0.67010Y3.599-2.929
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3562.198-1.842
MRQ0.5802.042-1.462
TTM0.5802.121-1.541
YOY0.8602.907-2.047
5Y0.6703.682-3.012
10Y3.5994.114-0.515
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BioLight Life Sciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---168.807-168.8070%28.626-690%199.557-185%35.737-572%
Book Value Per Share--1173.2781173.2780%1342.084-13%1403.593-16%962.598+22%
Current Ratio--7.1077.1070%15.379-54%13.286-47%9.079-22%
Debt To Asset Ratio--0.0580.0580%0.043+36%0.081-28%0.259-78%
Debt To Equity Ratio--0.0620.0620%0.045+38%0.088-29%0.688-91%
Dividend Per Share----0%-0%-0%-0%
Eps---171.473-171.4730%8.347-2154%139.621-223%-149.326-13%
Free Cash Flow Per Share---210.610-210.6100%-232.768+11%-312.982+49%-442.274+110%
Free Cash Flow To Equity Per Share---221.208-221.2080%-212.773-4%-113.928-48%-87.401-60%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--996.514--------
Intrinsic Value_10Y_min---756.015--------
Intrinsic Value_1Y_max---171.887--------
Intrinsic Value_1Y_min---255.767--------
Intrinsic Value_3Y_max---309.350--------
Intrinsic Value_3Y_min---617.120--------
Intrinsic Value_5Y_max---197.133--------
Intrinsic Value_5Y_min---809.821--------
Market Cap1910122576.000-63%3111843200.0003111843200.0000%5280980960.000-41%4330953536.000-28%8986606172.780-65%
Net Profit Margin---124.556-124.5560%127.333-198%-90.712-27%-74.629-40%
Operating Margin---163.841-163.8410%-3534.333+2057%-821.216+401%-453.963+177%
Operating Ratio--164.841164.8410%3535.333-95%820.310-80%454.409-64%
Pb Ratio0.356-63%0.5800.5800%0.860-33%0.670-14%3.599-84%
Pe Ratio-2.434+39%-3.966-3.9660%138.246-103%25.869-115%9.499-142%
Price Per Share417.400-63%680.000680.0000%1154.000-41%946.400-28%1963.753-65%
Price To Free Cash Flow Ratio-1.982+39%-3.229-3.2290%-4.958+54%-3.192-1%-4.207+30%
Price To Total Gains Ratio-2.473+39%-4.028-4.0280%40.313-110%5.712-171%5.339-175%
Quick Ratio--1.2031.2030%0.001+88538%2.141-44%1.278-6%
Return On Assets---0.138-0.1380%0.006-2412%0.044-415%-0.252+83%
Return On Equity---0.148-0.1480%0.006-2445%0.049-402%-0.747+406%
Total Gains Per Share---168.807-168.8070%28.626-690%199.557-185%35.737-572%
Usd Book Value--14604224.00014604224.0000%16705424.000-13%17471049.600-16%11981817.600+22%
Usd Book Value Change Per Share---0.459-0.4590%0.078-690%0.543-185%0.097-572%
Usd Book Value Per Share--3.1913.1910%3.650-13%3.818-16%2.618+22%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.466-0.4660%0.023-2154%0.380-223%-0.406-13%
Usd Free Cash Flow---2621536.000-2621536.0000%-2897344.000+11%-3895801.600+49%-5505144.000+110%
Usd Free Cash Flow Per Share---0.573-0.5730%-0.633+11%-0.851+49%-1.203+110%
Usd Free Cash Flow To Equity Per Share---0.602-0.6020%-0.579-4%-0.310-48%-0.238-60%
Usd Market Cap5195533.407-63%8464213.5048464213.5040%14364268.211-41%11780193.618-28%24443568.790-65%
Usd Price Per Share1.135-63%1.8501.8500%3.139-41%2.574-28%5.341-65%
Usd Profit---2134384.000-2134384.0000%103904.000-2154%1737916.800-223%-1858712.000-13%
Usd Revenue--17136.00017136.0000%816.000+2000%222006.400-92%266968.000-94%
Usd Total Gains Per Share---0.459-0.4590%0.078-690%0.543-185%0.097-572%
 EOD+3 -5MRQTTM+0 -0YOY+10 -235Y+11 -2210Y+15 -18

3.2. Fundamental Score

Let's check the fundamental score of BioLight Life Sciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.434
Price to Book Ratio (EOD)Between0-10.356
Net Profit Margin (MRQ)Greater than0-124.556
Operating Margin (MRQ)Greater than0-163.841
Quick Ratio (MRQ)Greater than11.203
Current Ratio (MRQ)Greater than17.107
Debt to Asset Ratio (MRQ)Less than10.058
Debt to Equity Ratio (MRQ)Less than10.062
Return on Equity (MRQ)Greater than0.15-0.148
Return on Assets (MRQ)Greater than0.05-0.138
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of BioLight Life Sciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.696
Ma 20Greater thanMa 50469.990
Ma 50Greater thanMa 100484.452
Ma 100Greater thanMa 200504.903
OpenGreater thanClose448.200
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in ILS. All numbers in thousands.

Summary
Total Assets57,011
Total Liabilities3,319
Total Stockholder Equity53,168
 As reported
Total Liabilities 3,319
Total Stockholder Equity+ 53,168
Total Assets = 57,011

Assets

Total Assets57,011
Total Current Assets18,024
Long-term Assets38,987
Total Current Assets
Cash And Cash Equivalents 13,392
Short-term Investments 2,987
Net Receivables 63
Other Current Assets 244
Total Current Assets  (as reported)18,024
Total Current Assets  (calculated)16,686
+/- 1,338
Long-term Assets
Property Plant Equipment 3,336
Other Assets 90
Long-term Assets  (as reported)38,987
Long-term Assets  (calculated)3,426
+/- 35,561

Liabilities & Shareholders' Equity

Total Current Liabilities2,536
Long-term Liabilities783
Total Stockholder Equity53,168
Total Current Liabilities
Accounts payable 301
Total Current Liabilities  (as reported)2,536
Total Current Liabilities  (calculated)301
+/- 2,235
Long-term Liabilities
Other Liabilities 783
Long-term Liabilities  (as reported)783
Long-term Liabilities  (calculated)783
+/-0
Total Stockholder Equity
Common Stock11,443
Other Stockholders Equity 8,065
Total Stockholder Equity (as reported)53,168
Total Stockholder Equity (calculated)19,508
+/- 33,660
Other
Capital Stock11,443
Common Stock Shares Outstanding 4,576
Net Invested Capital 53,168
Net Tangible Assets 52,482
Net Working Capital 15,488
Property Plant and Equipment Gross 5,688



Balance Sheet

Currency in ILS. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312006-12-312005-12-31
> Total Assets 
20,390
48,163
22,489
10,139
29,632
41,891
34,332
40,434
63,271
35,313
24,763
90,282
74,951
64,829
64,171
57,011
57,01164,17164,82974,95190,28224,76335,31363,27140,43434,33241,89129,63210,13922,48948,16320,390
   > Total Current Assets 
0
0
0
0
0
0
21,009
32,432
53,439
30,031
19,860
62,513
40,712
51,460
34,004
18,024
18,02434,00451,46040,71262,51319,86030,03153,43932,43221,009000000
       Cash And Cash Equivalents 
2,310
5,072
9,624
5,413
4,751
28,497
17,716
22,196
50,697
25,474
15,355
43,058
35,346
29,988
33,467
13,392
13,39233,46729,98835,34643,05815,35525,47450,69722,19617,71628,4974,7515,4139,6245,0722,310
       Short-term Investments 
17,333
38,750
10,996
2,158
7,029
610
185
6,408
385
417
412
387
4,604
19,961
0
2,987
2,987019,9614,6043874124173856,4081856107,0292,15810,99638,75017,333
       Net Receivables 
130
126
445
308
237
959
1,584
813
866
1,669
512
725
565
92
3
63
633925657255121,6698668131,584959237308445126130
       Inventory 
0
0
0
0
0
583
1,055
976
991
2,494
2,846
0
0
0
0
0
000002,8462,4949919761,05558300000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
5,282
4,903
27,769
34,239
13,369
30,167
38,987
38,98730,16713,36934,23927,7694,9035,282000000000
       Property Plant Equipment 
0
176
1,095
1,790
1,663
947
911
819
743
1,287
922
304
714
3,163
3,257
3,336
3,3363,2573,1637143049221,2877438199119471,6631,7901,0951760
       Goodwill 
0
0
0
0
0
0
4,678
3,873
3,873
3,873
3,873
3,873
3,873
112
112
0
01121123,8733,8733,8733,8733,8733,8734,678000000
       Long Term Investments 
0
0
0
0
0
0
0
0
79
0
0
20,006
0
0
0
0
000020,006007900000000
       Intangible Assets 
263
994
0
0
0
0
12,307
7,106
2,996
37
37
37
37
37
37
0
03737373737372,9967,10612,3070000994263
       Other Assets 
0
40
90
100
52
38
105
77
2,141
85
71
3,549
1,003
0
946
90
9094601,0033,54971852,14177105385210090400
> Total Liabilities 
2,689
40,154
9,182
7,417
6,085
4,553
12,223
14,696
16,210
18,903
16,732
12,486
6,804
4,722
2,754
3,319
3,3192,7544,7226,80412,48616,73218,90316,21014,69612,2234,5536,0857,4179,18240,1542,689
   > Total Current Liabilities 
1,862
2,312
3,645
3,553
3,566
1,874
4,898
6,552
6,605
6,988
7,259
5,021
3,571
2,561
2,211
2,536
2,5362,2112,5613,5715,0217,2596,9886,6056,5524,8981,8743,5663,5533,6452,3121,862
       Accounts payable 
74
331
550
639
391
209
1,365
943
873
2,776
737
1,386
221
580
146
301
3011465802211,3867372,7768739431,36520939163955033174
       Other Current Liabilities 
1,787
1,980
3,095
2,914
3,175
1,665
3,533
5,609
859
794
837
211
161
1,522
0
0
001,5221612118377948595,6093,5331,6653,1752,9143,0951,9801,787
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
11,915
9,473
7,465
3,233
2,161
543
783
7835432,1613,2337,4659,47311,915000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
450
929
443
527
527443929450000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
11,915
9,273
5,177
2,225
0
0
0
0002,2255,1779,27311,915000000000
> Total Stockholder Equity
17,701
8,008
4,964
0
22,882
38,285
12,573
28,403
34,644
10,841
6,100
82,331
68,863
59,217
60,702
53,168
53,16860,70259,21768,86382,3316,10010,84134,64428,40312,57338,28522,88204,9648,00817,701
   Common Stock
289
331
701
917
1,765
3,423
3,423
5,215
6,519
6,519
9,088
11,359
11,359
11,359
11,401
11,443
11,44311,40111,35911,35911,3599,0886,5196,5195,2153,4233,4231,765917701331289
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 0000000000000000
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
14,217
20,595
18,591
10,040
6,390
6,166
5,289
8,856
7,835
8,065
8,0657,8358,8565,2896,1666,39010,04018,59120,59514,217000000



Balance Sheet

Currency in ILS. All numbers in thousands.




Cash Flow

Currency in ILS. All numbers in thousands.




Income Statement

Currency in ILS. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue63
Cost of Revenue-0
Gross Profit063
 
Operating Income (+$)
Gross Profit0
Operating Expense-10,385
Operating Income-10,322-10,385
 
Operating Expense (+$)
Research Development3,530
Selling General Administrative2,671
Selling And Marketing Expenses0
Operating Expense10,3856,201
 
Net Interest Income (+$)
Interest Income8
Interest Expense-66
Other Finance Cost-254
Net Interest Income-312
 
Pretax Income (+$)
Operating Income-10,322
Net Interest Income-312
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,687-10,322
EBIT - interestExpense = -10,388
-7,847
-7,781
Interest Expense66
Earnings Before Interest and Taxes (EBIT)-10,322-8,621
Earnings Before Interest and Taxes (EBITDA)-8,033
 
After tax Income (+$)
Income Before Tax-8,687
Tax Provision-0
Net Income From Continuing Ops-8,687-8,687
Net Income-7,847
Net Income Applicable To Common Shares-7,847
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0312
 

Technical Analysis of BioLight Life Sciences Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BioLight Life Sciences Ltd. The general trend of BioLight Life Sciences Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BioLight Life Sciences Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioLight Life Sciences Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 442.00 < 530.00 < 558.30.

The bearish price targets are: .

Tweet this
BioLight Life Sciences Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioLight Life Sciences Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioLight Life Sciences Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioLight Life Sciences Ltd. The current macd is -12.11489887.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the BioLight Life Sciences Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for BioLight Life Sciences Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the BioLight Life Sciences Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
BioLight Life Sciences Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBioLight Life Sciences Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioLight Life Sciences Ltd. The current adx is 26.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell BioLight Life Sciences Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
BioLight Life Sciences Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioLight Life Sciences Ltd. The current sar is 472.91.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BioLight Life Sciences Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioLight Life Sciences Ltd. The current rsi is 33.70. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
BioLight Life Sciences Ltd Daily Relative Strength Index (RSI) ChartBioLight Life Sciences Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioLight Life Sciences Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the BioLight Life Sciences Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
BioLight Life Sciences Ltd Daily Stochastic Oscillator ChartBioLight Life Sciences Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioLight Life Sciences Ltd. The current cci is -223.49784738.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
BioLight Life Sciences Ltd Daily Commodity Channel Index (CCI) ChartBioLight Life Sciences Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioLight Life Sciences Ltd. The current cmo is -41.08142167.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
BioLight Life Sciences Ltd Daily Chande Momentum Oscillator (CMO) ChartBioLight Life Sciences Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioLight Life Sciences Ltd. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
BioLight Life Sciences Ltd Daily Williams %R ChartBioLight Life Sciences Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BioLight Life Sciences Ltd.

BioLight Life Sciences Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioLight Life Sciences Ltd. The current atr is 18.88.

BioLight Life Sciences Ltd Daily Average True Range (ATR) ChartBioLight Life Sciences Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioLight Life Sciences Ltd. The current obv is -164,118.

BioLight Life Sciences Ltd Daily On-Balance Volume (OBV) ChartBioLight Life Sciences Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioLight Life Sciences Ltd. The current mfi is 20.73.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
BioLight Life Sciences Ltd Daily Money Flow Index (MFI) ChartBioLight Life Sciences Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioLight Life Sciences Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

BioLight Life Sciences Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioLight Life Sciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.696
Ma 20Greater thanMa 50469.990
Ma 50Greater thanMa 100484.452
Ma 100Greater thanMa 200504.903
OpenGreater thanClose448.200
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of BioLight Life Sciences Ltd with someone you think should read this too:
  • Are you bullish or bearish on BioLight Life Sciences Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BioLight Life Sciences Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioLight Life Sciences Ltd

I send you an email if I find something interesting about BioLight Life Sciences Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about BioLight Life Sciences Ltd.

Receive notifications about BioLight Life Sciences Ltd in your mailbox!